Over 80% of rare diseases may be genetic in origin, and have a significant impact on our healthcare system. Children with rare disease often have a long diagnostic journey, taking over 7 years to reach a diagnosis through 8 different physicians and nearly $20,000 invested in the wrong genetic tests. Whole-genome sequencing (WGS) is a comprehensive method for analyzing entire genomes, and rapidly dropping sequencing costs means that clinicians can now cost-effectively use this one comprehensive test to get a critically infant diagnosed and out of the NICU quicker, or end the pediatric rare disease odyssey much sooner, avoiding unnecessary tests and interventions. Join this webinar to learn what WGS is and is not, how it impacts patients, the value for clinicians in optimizing patient care, and learn how to access and use a peer-reviewed economic value model.
Featured Speakers

Austin Larson
Assistant Professor
University of Colorado School of Medicine
Dr. Larson is an Assistant Professor at the University of Colorado School of Medicine in the Department of Pediatrics. He practices at Children’s Hospital Colorado and focuses on mitochondrial diseases, ocular genetics, implementation of broad genetic testing in clinical practice, medical informatics and clinical trials for rare diseases. He also has clinics in western Colorado and uses telemedicine as outreach for rural patients. He is the program director of the medical genetics residency program.

Danny Miller
CEO
MEPAN Foundation

Brock Schroeder
Senior Director of Market Access Strategy & HEOR
Illumina
Brock Schroeder is Senior Director of Market Access Strategy & HEOR at Illumina, where he leads efforts to generate evidence of clinical and economic utility of current and emerging clinical applications of next generation sequencing (NGS) to support health technology assessment (HTA), payer coverage, and patient access to clinical genomic tools. Brock’s industry experience includes multiple therapeutic areas, including oncology, rare diseases, and reproductive health. Brock has authored 25 peer-reviewed manuscripts and >50 scientific congress abstracts. He received his BA in Biology from Washington University, and his PhD in Neuroscience from University of Wisconsin-Madison.
Time: 2pm ET / 11am PT
Duration: 1 Hour
Register now for this webinar